New treatments for neurodegenerative diseases like Alzheimer's, Parkinson's, and motor neuron disease (MND) could be unlocked thanks to microscopic medicines developed by researchers at the University ...

A team from the University of Barcelona has designed and validated in animal models an innovative compound with a pioneering mechanism of action for the treatment of Alzheimer's disease.

Alzheimer's disease affects millions of people worldwide, yet the illness is hardest to catch at the very beginning, when new ...

GLP-1 receptor agonist indications continue to expand beyond glycaemic and weight control, with benefits now shown in chronic kidney disease in type 2 diabetes, obesity-related heart failure, knee ...

Research roundtable highlights early detection, biomarkers, interventions ...

After identifying that accumulation of toxic tau and amyloid proteins in the brain are a feature of Alzheimer’s disease, researchers have, understandably, been working on treatments that reduce or ...

Expecting pivotal data this year, the company has raised a Series C round to support the launch of a noninvasive device ...

Smith Could a simple blood test predict your risk of getting dementia years, or even decades, before you experience memory ...

Biomed Industries, Inc. Presented Breakthrough Unified Theory Linking Alzheimer’s Disease, Obesity and Cardiovascular ...

The NHS spending watchdog must look again at its decision after drug manufacturers successfully appealed against Nice's ruling that the treatments were not cost-effective ...

The findings could help clinicians use neuropsychiatric symptoms to prepare patients and families for a type of dementia ...

Now, with the passing of House Bill 565, also known as Jill’s Law, all Mississippians will have access to biomarker testing ...